News

Anuh Pharma announced that the 66th Annual General Meeting(AGM) of the company will be held on 12 August 2026.

Anuh Pharma announced that the Board of Directors of the Company at its meeting held on 20 May 2026, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 30%) , subject to the approval of the shareholders.

Net profit of Anuh Pharma declined 6.26% to Rs 11.68 crore in the quarter ended March 2026 as against Rs 12.46 crore during the previous quarter ended March 2025. Sales rose 2.01% to Rs 202.12 crore in the quarter ended March 2026 as against Rs 198.14 crore during the previous quarter ended March 2025.For the full year,net profit declined 13.31% to Rs 41.05 crore in the year ended March 2026 as against Rs 47.35 crore during the previous year ended March 2025. Sales rose 16.65% to Rs 771.66 crore in the year ended March 2026 as against Rs 661.51 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales202.12198.14 2 771.66661.51 17 OPM %9.849.43 -8.009.21 - PBDT18.5220.05 -8 65.6169.75 -6 PBT15.5217.29 -10 54.2361.01 -11 NP11.6812.46 -6 41.0547.35 -13 Powered by Capital Market - Live News

Anuh Pharma will hold a meeting of the Board of Directors of the Company on 20 May 2026.

Anuh Pharma announced that its manufacturing facilities located at E-17/3, E-17/4 and E-18, MIDC, Tarapur (Boisar), Palghar, Maharashtra have undergone inspection conducted by the United States Food and Drug Administration (USFDA). The inspection was completed with no Form 483 observations issued.Powered by Capital Market - Live News